Covered recipient · General Payments record
ROSANA RODRIGUEZ
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$12,835.78
- Reported across 109 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $264.03 | 14 |
| Education | $94.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $94.00 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $54.32 | 3 |
| PFIZER INC. | $47.72 | 2 |
| Organon LLC | $41.84 | 4 |
| Hologic Sales and Service, LLC | $31.71 | 1 |
| Biogen, Inc. | $26.09 | 1 |
| ConvaTec Inc. | $24.74 | 1 |
| Evofem Biosciences, Inc. | $19.22 | 1 |
| Smith & Nephew, Inc. | $18.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $94.00 | 02/08/2024 | Education | Undisputed | 01/23/2026 | 1139344004 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $20.89 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086230288 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $14.17 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086163542 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $19.26 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086115630 | CMS |
| Biogen, Inc. | $26.09 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104812735 | CMS |
| ConvaTec Inc. | $24.74 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151383723 | CMS |
| Evofem Biosciences, Inc. | $19.22 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091274102 | CMS |
| Hologic Sales and Service, LLC | $31.71 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084879715 | CMS |
| Organon Llc | $1.50 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136242238 | CMS |
| Organon Llc | $1.62 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136242242 | CMS |
| Organon Llc | $11.00 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136242246 | CMS |
| Organon Llc | $27.72 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136242234 | CMS |
| PFIZER INC. | $24.27 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131505651 | CMS |
| PFIZER INC. | $23.45 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131784398 | CMS |
| Smith+Nephew, Inc. | $18.39 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149537493 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.